CINCINNATI, OH, August 14, 2018 - Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the `Company` or `Callitas`) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today it has signed a letter of intent with Lifestyles to supply unique finished goods for retail sale. `At LifeStyles, our mission is to spark billions of joyful moments every day, regardless of gender, age, race, religion and sexuality. We are committed to continuous innovation that can help people enjoy healthier and more fulfilling intimacy, and the collaboration with Callitas is an important part of this our commitment,` said, Jeyan Heper, CEO at LifeStyles....
|
